title: Nucleic acid aptamers for targeting of shRNA-based cancer therapeutics.
abstract: Aptamers are nucleic acid ligands which have been validated to bind to epitopes with a specificity similar to that of monoclonal antibodies. Aptamers have been primarily investigated for their direct function in terms of inhibition of protein targets; however, recent evidence gives reason to actively explore aptamers as targeting moieties for delivery of anticancer therapeutics. Many aptamers have been developed to bind to extracellular membrane domains of proteins overexpressed on cancer cells and have the potential to be modified for use in targeting cancer therapeutics. The use of DNA vector-based short hairpin RNA (shRNA) for RNA interference (RNAi) is a precise means for the disruption of target gene expression but its clinical usage in cancer is limited by obstacles related to delivery into cancer cells. Nucleic acid aptamers are attractive candidates for targeting of shRNA therapies. Their small size, ease of production and modification, and high specificity are valued attributes in comparison to other targeting moieties currently being tested. Here we review the development of aptamers directed to PSMA, Nucleolin, HER-3, RET, TN-C, and MUC1 and focus on their potential for use in targeting of shRNA-based cancer therapeutics.
authors.affiliation: Mary Crowley Cancer Research Centers, Dallas, TX, USA.
authors.forename: John S
authors.initials: JS
authors.lastname: Vorhies
authors.forename: John J
authors.initials: JJ
authors.lastname: Nemunaitis
references.citation: Anticancer Res. 1987 Sep-Oct;7(5B):927-35
references.pmid: 2449118
references.citation: Cancer Res. 1989 Sep 15;49(18):4968-71
references.pmid: 2569928
references.citation: Curr Pharm Des. 2004;10(24):3033-44
references.pmid: 15379666
references.citation: J Biol Chem. 1997 Dec 26;272(52):33327-37
references.pmid: 9407125
references.citation: Cell. 1990 Nov 2;63(3):601-8
references.pmid: 2225067
references.citation: Int J Biochem Cell Biol. 2004 Jun;36(6):986-90
references.pmid: 15094113
references.citation: Clin Cancer Res. 1998 Feb;4(2):295-302
references.pmid: 9516914
references.citation: Biochim Biophys Acta. 1999 Oct 8;1455(2-3):301-13
references.pmid: 10571020
references.citation: Oncogene. 1988 Mar;2(3):283-7
references.pmid: 3281095
references.citation: J Cell Biochem. 2004 Feb 15;91(3):528-39
references.pmid: 14755683
references.citation: Eur J Biochem. 2004 Jan;271(2):303-17
references.pmid: 14717698
references.citation: Micron. 2000 Apr;31(2):117-20
references.pmid: 10588056
references.citation: Dis Colon Rectum. 1998 Oct;41(10):1262-72
references.pmid: 9788390
references.citation: Nucleic Acids Res. 2006 Jun 01;34(10):e73
references.pmid: 16740739
references.citation: J Biol Chem. 1999 Sep 10;274(37):26369-77
references.pmid: 10473594
references.citation: Oligonucleotides. 2005 Fall;15(3):183-95
references.pmid: 16201906
references.citation: J Cell Biochem. 1993 Sep;53(1):61-73
references.pmid: 7901229
references.citation: J Biol Chem. 2001 Dec 28;276(52):48644-54
references.pmid: 11590140
references.citation: Nucleic Acids Symp Ser (Oxf). 2005;(49):351-2
references.pmid: 17150778
references.citation: Int J Biol Markers. 2000 Oct-Dec;15(4):343-56
references.pmid: 11192832
references.citation: Pathol Int. 1997 Jul;47(7):454-60
references.pmid: 9234384
references.citation: Nucleic Acids Res. 2005 May 24;33(9):2942-51
references.pmid: 15914669
references.citation: Int J Cancer. 1997 Jul 3;72(1):87-94
references.pmid: 9212228
references.citation: Proc Natl Acad Sci U S A. 2006 Apr 18;103(16):6315-20
references.pmid: 16606824
references.citation: Cancer. 1998 Dec 1;83(11):2259-69
references.pmid: 9840525
references.citation: Chem Biol. 2005 Jan;12(1):25-33
references.pmid: 15664512
references.citation: J Biol Chem. 2002 Oct 4;277(40):37492-502
references.pmid: 12147681
references.citation: Pharm Res. 2006 Feb;23(2):303-11
references.pmid: 16411148
references.citation: Expert Opin Drug Deliv. 2005 Jan;2(1):145-57
references.pmid: 16296741
references.citation: Nucl Med Biol. 2000 Apr;27(3):289-97
references.pmid: 10832086
references.citation: Cancer Res. 2001 Apr 1;61(7):2929-34
references.pmid: 11306470
references.citation: Q J Nucl Med. 2002 Jun;46(2):131-7
references.pmid: 12114876
references.citation: Nucleic Acids Res. 2003 Nov 1;31(21):e130
references.pmid: 14576330
references.citation: Nucleic Acids Res. 1991 Sep 11;19(17):4695-700
references.pmid: 1891360
references.citation: Biochemistry. 1995 Sep 12;34(36):11363-72
references.pmid: 7547864
references.citation: Cancer Res. 2001 Sep 15;61(18):6846-50
references.pmid: 11559560
references.citation: Oncogene. 1999 Apr 1;18(13):2241-51
references.pmid: 10327070
references.citation: Nucleic Acids Res. 2002 Oct 15;30(20):e108
references.pmid: 12384610
references.citation: J Med Genet. 2000 Nov;37(11):817-27
references.pmid: 11073534
references.citation: Int J Biochem Cell Biol. 2005 May;37(5):1066-83
references.pmid: 15743679
references.citation: Science. 1990 Aug 3;249(4968):505-10
references.pmid: 2200121
references.citation: Science. 1989 May 12;244(4905):707-12
references.pmid: 2470152
references.citation: Nat Rev Cancer. 2004 Jan;4(1):45-60
references.pmid: 14681689
references.citation: J Nucl Med. 2006 Apr;47(4):668-78
references.pmid: 16595502
references.citation: Ophthalmology. 2007 Sep;114(9):1702-12
references.pmid: 17509689
references.citation: J Virol. 1991 Dec;65(12):6811-6
references.pmid: 1942253
references.citation: Cancer Res. 1995 Feb 15;55(4):907-14
references.pmid: 7531617
references.citation: J Clin Oncol. 2005 Jul 20;23(21):4591-601
references.pmid: 15837970
references.citation: Anal Bioanal Chem. 2007 Jan;387(1):171-82
references.pmid: 17072603
references.citation: Cancer Res. 1994 Apr 1;54(7):1807-11
references.pmid: 7511053
references.citation: J Biotechnol. 2000 Aug 25;81(2-3):167-78
references.pmid: 10989176
references.citation: Cancer Res. 2003 Aug 15;63(16):5011-20
references.pmid: 12941828
references.citation: Hum Pathol. 1991 Jul;22(7):636-43
references.pmid: 1712747
references.citation: Cancer Res. 1990 Jul 1;50(13):4087-91
references.pmid: 1972347
references.citation: Proc Natl Acad Sci U S A. 1987 Mar;84(6):1472-6
references.pmid: 3470736
references.citation: Mol Cancer Ther. 2006 Dec;5(12):2957-62
references.pmid: 17172400
references.citation: Cancer Res. 1995 Apr 1;55(7):1441-3
references.pmid: 7882349
references.citation: Am J Pathol. 2002 Oct;161(4):1223-33
references.pmid: 12368196
references.citation: Gene Ther. 2006 May;13(9):761-72
references.pmid: 16453011
references.citation: Cancer Res. 2000 Nov 15;60(22):6281-7
references.pmid: 11103784
references.citation: Nature. 1990 Aug 30;346(6287):818-22
references.pmid: 1697402
references.citation: Biochimie. 2006 Jul;88(7):897-904
references.pmid: 16540230
references.citation: Indian J Cancer. 2007 Jan-Mar;44(1):1-5
references.pmid: 17401217
references.citation: Subcell Biochem. 2007;41:125-44
references.pmid: 17484127
references.citation: Nat Biotechnol. 2004 Nov;22(11):1423-8
references.pmid: 15502817
references.citation: Proc Natl Acad Sci U S A. 2007 Mar 6;104(10):3742-6
references.pmid: 17360423
references.citation: J Biol Chem. 1995 Oct 27;270(43):25702-8
references.pmid: 7592749
references.citation: Q J Nucl Med Mol Imaging. 2007 Dec;51(4):292-6
references.pmid: 17464274
references.citation: Int J Cancer. 1992 Nov 11;52(5):688-92
references.pmid: 1385335
references.citation: Annu Rev Biochem. 1995;64:763-97
references.pmid: 7574500
references.citation: Nucleic Acids Symp Ser (Oxf). 2004;(48):195-6
references.pmid: 17150545
references.citation: Front Biosci. 2006 Jan 01;11:89-112
references.pmid: 16146716
references.citation: Nat Rev Microbiol. 2006 Aug;4(8):588-96
references.pmid: 16845429
references.citation: Nucleic Acids Res. 2003 Apr 15;31(8):2097-107
references.pmid: 12682360
references.citation: Nat Rev Drug Discov. 2006 Feb;5(2):123-32
references.pmid: 16518379
references.citation: Curr Pharm Des. 2004;10(19):2311-34
references.pmid: 15279611
references.citation: Pharm Res. 2000 Dec;17(12):1503-10
references.pmid: 11303960
references.citation: Blood. 1993 Jun 15;81(12):3271-6
references.pmid: 8507864
references.citation: Exp Cell Res. 2000 Dec 15;261(2):312-28
references.pmid: 11112338
references.citation: Biomaterials. 2007 Feb;28(5):869-76
references.pmid: 17055572
references.citation: J Cell Biol. 1988 Dec;107(6 Pt 2):2757-67
references.pmid: 2462568
references.citation: Cancer. 1998 Jun 1;82(11):2256-61
references.pmid: 9610707
references.citation: Biochimie. 2005 Sep-Oct;87(9-10):921-30
references.pmid: 15963620
references.citation: J Cell Biol. 2003 Nov 24;163(4):871-8
references.pmid: 14638862
references.citation: Biochemistry. 2001 Feb 27;40(8):2433-8
references.pmid: 11327864
references.citation: Nature. 2002 Sep 5;419(6902):90-4
references.pmid: 12214238
references.citation: Annu Rev Cell Biol. 1989;5:71-92
references.pmid: 2480799
references.citation: Nat Biotechnol. 2006 Aug;24(8):1005-15
references.pmid: 16823371
references.citation: Lab Invest. 1995 Oct;73(4):497-502
references.pmid: 7474921
references.citation: Biochemistry. 2002 Mar 19;41(11):3676-85
references.pmid: 11888284
references.citation: Cancer Res. 2002 Jul 15;62(14):4029-33
references.pmid: 12124337
references.citation: J Clin Invest. 2000 Oct;106(8):929-34
references.pmid: 11032851
references.citation: J Cell Sci. 1999 Mar;112 ( Pt 6):761-72
references.pmid: 10036227
references.citation: Adv Drug Deliv Rev. 2002 Sep 13;54(5):675-93
references.pmid: 12204598
references.citation: Proc Natl Acad Sci U S A. 2003 Aug 5;100(16):9226-31
references.pmid: 12874383
references.citation: FASEB J. 1999 Nov;13(14):1911-22
references.pmid: 10544174
references.citation: Bioconjug Chem. 1998 Sep-Oct;9(5):573-82
references.pmid: 9736491
references.citation: Cancer Res. 2004 Nov 1;64(21):7668-72
references.pmid: 15520166
references.citation: Glycobiology. 2005 Jan;15(1):1-9
references.pmid: 15329357
references.citation: Nucleic Acids Res. 2004 Oct 27;32(19):5757-65
references.pmid: 15509871
references.citation: Oncogene. 1999 Jul 1;18(26):3919-22
references.pmid: 10445857
references.citation: PLoS Biol. 2005 Apr;3(4):e123
references.pmid: 15769183
references.citation: Tumour Biol. 2006;27(6):289-301
references.pmid: 17033199
references.citation: Cancer Lett. 2006 Dec 8;244(2):143-63
references.pmid: 16632194